The Regulatory Challenge of Electronic Cigarettes (JAMA)

[Bill Godshall]

The Regulatory Challenge of Electronic Cigarettes (JAMA)
JAMA Network | JAMA | The Regulatory Challenge of Electronic Cigarettes


Two otherwise objective and knowledgeable researchers fall into the trap of endorsing FDA regulation of e-cigarettes without acknowledging that the "deeming" regulation (that FDA has stated its intent to propose and approve) would ban all e-cigarettes.

The authors also fail to acknowledge that the FSPTCA requires the Secretary of DHHS to determine that all new tobacco regulations would benefit public health (before approving any new tobacco regulation), that DHHS has not provided any evidence that regulating e-cigarette would (or even might) benefit public health, or that dozens of vapers and THR advocates have testified at FDA hearings/meetings and that more than 5,000 vapers submitted comments to FDA's docket stating that the "deeming" regulation would threaten consumer and public health.

Seems like most researchers ignore all the important legal and public health issues when advocating new regulations.

 

[k3vin]

Here is the conflict of interest disclosure at the end of the article..



Conflict of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Benowitz reported being a former member of the FDA Tobacco Products Scientific Advisory Committee; serving on a Pfizer smoking cessation medication advisory board; and having been an occasional consultant to GlaxoSmithKline and McNeil, pharmaceutical companies that market smoking cessation medications. Dr Goniewicz has received a research grant from Pfizer.

Additional Contributions: We thank Rachel Grana, PhD (University of California, San Francisco), and Z Morgan Benowitz-Fredericks, PhD (Bucknell University), for constructive comments and Scott Rostler for editorial assistance. None of the individuals were compensated for their contributions.

 

[Bill Godshall]

Dr Benowitz reported being a former member of the FDA Tobacco Products Scientific Advisory Committee

He must have recently resigned from the FDA's TPSAC (as I don't think his term had expired).

Sure enough, he's no longer on the TPSAC roster.

Roster of the Tobacco Products Scientific Advisory Committee
Roster of the Tobacco Products Scientific Advisory Committee
Applying for Membership on FDA Advisory Committees
As part of the food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. (More info)


Current Number of Vacancies: 0

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.



Chair
Jonathan M. Samet, M.D., M.S.
Expertise: Internal Medicine, Pulmonary,
Epidemiology, Tobacco Control, Public Health
Term: 02/16/10 - 1/31/14
Professor and Flora L. Thornton Chair
Department of Preventive Medicine
Keck School of Medicine
Director, Institute for Global Health
University of Southern California
Soto Street Building, Suite 330A
2001 N Soto Street, MC 9239
Los Angeles CA 90089-9239


Designated Federal Official
Caryn Cohen, M.S.
Center for Tobacco Products
Food and Drug Administration
9200 Corporate Blvd., Rm 320W
Rockville, MD 20850-3229
Phone: 1-877-CTP-1373
Fax: 240-276-3655
Email: Caryn.Cohen@fda.hhs.gov


Members
Warren K. Bickel, Ph.D.
Expertise: Addiction, Substance abuse, Psychology, Behavioral pharmacology
Term: 2/27/13-1/31/17
Director, Addiction Recovery Research Center
Virginia Tech Carilion Research Institute
Professor of Psychology
Virginia Polytechnic Institute and State University
2 Riverside Drive
Roanoke, Virginia 24016


Mark Stuart Clanton, M.D., M.P.H
Expertise: Oncology, Pediatrics
Term: 02/17/10 -1/31/14
Chief Medical Officer
American Cancer Society
High Plains Division
2433-A Ridgepoint Drive
Austin, Texas 78754


Joanna Cohen, Ph.D.
Expertise: Health policy and administration, Epidemiology, Global tobacco control, Nicotine dependence
Term: 2/27/13-1/31/17
Director, Institute for Global Tobacco Control
Johns Hopkins Bloomberg School of
Public Health
Johns Hopkins University
624 N. Broadway, Room 297
Baltimore, Maryland 21205


Thomas E. Eissenberg, Ph.D.
Expertise: Psychology, Potentially reduced exposure products, Waterpipes
Term: 08/01/11-1/31/15
Professor, Department of Psychology and
Institute for Drug and Alcohol Studies, and
Director, Clinical Behavioral Pharmacology Laboratory
Virginia Commonwealth University
Box 980205
Richmond, Virginia 23298


# Jonathan Daniel Heck, Ph.D., DABT
Expertise: Industry Representative
Term: 3/22/10 - 1/31/14
Lorillard Tobacco Company
A.W. Spears Research Center
420 N. English St.
P.O. Box 21688
Greensboro, North Carolina 27420-1688


* Patricia Nez Henderson, M.P.H., M.D.
Expertise: Public Health, Epidemiology
Term: 02/16/10 - 1/31/14
Vice President
Black Hills Center for American Indian Health
701 St. Joseph Street, Suite 204
Rapid City, South Dakota 57701


## Hampton H. Henton
Expertise: Industry Representative
Term: 2/27/13-1/31/17
6749 Frankfort Road
Versailles, Kentucky 40383


** Philip P. Huang, M.D., M.P.H.
Expertise: Chronic Disease Prevention, Tobacco Use Prevention, Cardiovascular Disease, State & Local Government
Term: 9/24/12 – 1/31/16
Austin/Travis County Health & Human Services Department
15 Waller Street
Austin, Texas 78702


Suchitra Krishnan-Sarin, Ph.D.
Expertise: Substance Abuse Behaviors in Children, Adolescents, and Adults
Term: 9/24/12 – 1/31/16
Yale University School of Medicine
S208
34 Park Street
New Haven, Connecticut 06519


Kurt M. Ribisl, M.A., Ph.D.
Expertise: Marketing, Advertising, Policy, Cancer Prevention
Term: 9/24/12 – 1/31/16
UNC Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Campus Box #7440; 316 Rosenau Hall
Chapel Hill, North Carolina 27599


As described in the charter of the committee, the membership includes:

* Representative of the General Public
** Employee of a state or local government or of the Federal Government.
# Representative of the tobacco manufacturing industry, non-voting
Alternate: Michael Ogden, Ph.D., R.J. Reynolds Incorporated
## Representative of the interests of tobacco growers, non-voting
Alternate: Luby Arnold Hamm, Jr.